Your browser doesn't support javascript.
loading
Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset.
Porcu, Luca; Fichera, Mario; Nanetti, Lorenzo; Rulli, Eliana; Giunti, Paola; Parkinson, Michael H; Durr, Alexandra; Ewenczyk, Claire; Boesch, Sylvia; Nachbauer, Wolfgang; Indelicato, Elisabetta; Klopstock, Thomas; Stendel, Claudia; Rodríguez de Rivera, Francisco Javier; Schöls, Ludger; Fleszar, Zofia; Giordano, Ilaria; Didszun, Claire; Castaldo, Anna; Rai, Myriam; Klockgether, Thomas; Pandolfo, Massimo; Schulz, Jörg B; Reetz, Kathrin; Mariotti, Caterina.
Afiliação
  • Porcu L; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Fichera M; Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, 20133, Italy.
  • Nanetti L; Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, 20133, Italy.
  • Rulli E; Laboratory of Methodology for Clinical Research, Oncology Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Giunti P; Department of Clinical and Movement Neurosciences, Ataxia Centre, UCL-Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Parkinson MH; Department of Clinical and Movement Neurosciences, Ataxia Centre, UCL-Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Durr A; Sorbonne Université, Paris Brain Institute (ICM Institut du Cerveau), AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, Paris, 75646, France.
  • Ewenczyk C; Sorbonne Université, Paris Brain Institute (ICM Institut du Cerveau), AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, Paris, 75646, France.
  • Boesch S; Department of Neurology, Medical University Innsbruck, Innsbruck, 6020, Austria.
  • Nachbauer W; Department of Neurology, Medical University Innsbruck, Innsbruck, 6020, Austria.
  • Indelicato E; Department of Neurology, Medical University Innsbruck, Innsbruck, 6020, Austria.
  • Klopstock T; Department of Neurology, Friedrich Baur Institute, University Hospital, LMU, Munich, 80336, Germany.
  • Stendel C; German Center for Neurodegenerative Diseases (DZNE), Munich, 81377, Germany.
  • Rodríguez de Rivera FJ; Munich Cluster for Systems Neurology (SyNergy), Munich, 81377, Germany.
  • Schöls L; Department of Neurology, Friedrich Baur Institute, University Hospital, LMU, Munich, 80336, Germany.
  • Fleszar Z; German Center for Neurodegenerative Diseases (DZNE), Munich, 81377, Germany.
  • Giordano I; Reference Unit of Hereditary Ataxias and Paraplegias, Department of Neurology, IdiPAZ, Hospital Universitario La Paz, Madrid, 28046, Spain.
  • Didszun C; Department of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, 72076, Germany.
  • Castaldo A; German Center for Neurodegenerative Diseases (DZNE), Tübingen, 72076, Germany.
  • Rai M; Department of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, 72076, Germany.
  • Klockgether T; Department of Neurology, University Hospital of Bonn, Bonn, 53127, Germany.
  • Pandolfo M; Department of Neurology, RWTH Aachen University, Aachen, 52074, Germany.
  • Schulz JB; Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, 20133, Italy.
  • Reetz K; Laboratory of Experimental Neurology, Université Libre de Bruxelles, Brussels, 1070, Belgium.
  • Mariotti C; Department of Neurology, University Hospital of Bonn, Bonn, 53127, Germany.
Ann Clin Transl Neurol ; 10(11): 2000-2012, 2023 11.
Article em En | MEDLINE | ID: mdl-37641437
BACKGROUND: The Scale for Assessment and Rating of Ataxia (SARA) is widely used in different types of ataxias and has been chosen as the primary outcome measure in the European natural history study for Friedreich ataxia (FA). METHODS: To assess distribution and longitudinal changes of SARA scores and its single items, we analyzed SARA scores of 502 patients with typical-onset FA (<25 years) participating in the 4-year prospective European FA Consortium for Translational Studies (EFACTS). Pattern of disease progression was determined using linear mixed-effects regression models. The chosen statistical model was re-fitted in order to estimate parameters and predict disease progression. Median time-to-change and rate of score progression were estimated using the Kaplan-Meier method and weighted linear regression models, respectively. RESULTS: SARA score at study enrollment and age at onset were the major predictive factors of total score progression during the 4-year follow-up. To a less extent, age at evaluation also influenced the speed of SARA progression, while disease duration did not improve the prediction of the statistical model. Temporal dynamics of total SARA and items showed a great variability in the speed of score increase during disease progression. Gait item had the highest annual progression rate, with median time for one-point score increase of 1 to 2 years. INTERPRETATION: Analyses of statistical properties of SARA suggest a variable sensitivity of the scale at different disease stages, and provide important information for population selection and result interpretation in future clinical trials.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ataxia de Friedreich / Ataxias Espinocerebelares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Clin Transl Neurol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ataxia de Friedreich / Ataxias Espinocerebelares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Clin Transl Neurol Ano de publicação: 2023 Tipo de documento: Article